Ethan R. Balkin - Concepedia

Author

Ethan R. Balkin

University of Washington ORCID

Also Known As

Balkin, E. R., Ethan Balkin, Ethan R Balkin, Ethan R. Balkin

Publications

333

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center University of Missouri Los Alamos National Laboratory University of Washington Medical Center

About

Ethan R. Balkin is an author at University of Washington specializing in engineering, chemical engineering, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	97
2	Medicine	3	3	89
3	Chemical Engineering	3	3	78
4	Chemistry	3	3	85
5	Natural Sciences	1	1	16

Ethan R. Balkin

Publications

314

Citations

H-Index

Page 1

	Year	Citations
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model Johnnie J. Orozco, Tom Bäck, Aimee L. Kenoyer, Blood	2013	69
Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine Ethan R. Balkin, Donald K. Hamlin, Katherine Gagnon, Applied Sciences Wet Chemistry MethodSolvent ExtractionChemical EngineeringAttenuation CorrectionsEngineering	2013	50
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment Johnnie J. Orozco, Aimee L. Kenoyer, Ethan R. Balkin, Blood	2015	35
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use Jane E. Burnett, Ethan R. Balkin American Journal of Health-System Pharmacy	2006	27
<i>In Vivo</i> Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model Ethan R. Balkin, Aimee L. Kenoyer, Johnnie J. Orozco, Cancer Research	2014	22
Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam Tara Mastren, Valery Radchenko, H. Bach, Nuclear Medicine and Biology Cancer TherapyOncologyBulk ProductionRadiation TherapyProton Beam	2017	22
Accelerator-based production of the 99mTc-186Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2) Matthew Gott, Connor R. Hayes, Donald E. Wycoff, Applied Radiation and Isotopes Accelerator-based ProductionInorganic ChemistryEngineeringChemistry99Mtc-186re Diagnostic-therapeutic Pair	2016	19
Comparative biodistributions and dosimetry of [177Lu]DOTA-anti-bcl-2-PNA-Tyr3-octreotate and [177Lu]DOTA-Tyr3-octreotate in a mouse model of B-cell lymphoma/leukemia Ethan R. Balkin, Dijie Liu, Fang Jia, Nuclear Medicine and Biology Hematological MalignancyTumor BiologyComparative BiodistributionsLymphoid NeoplasiaMedicine	2013	17
Deuteron irradiation of W and WO3 for production of high specific activity 186Re: Challenges associated with thick target preparation Ethan R. Balkin, Katherine Gagnon, Kevin Strong, Applied Radiation and Isotopes Chemical EngineeringEngineeringHigh-energy Nuclear ReactionNatural SciencesThick Target Preparation	2016	16
Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model Johnnie J. Orozco, Ethan R. Balkin, Ted Gooley, PLoS ONE	2014	14

Page 1